- Hypertension, renin-angiotensinaldosterone-system-blocking agents, and COVID-19
-
Kang SH, Lee DH, Han KD, Jung JH, Park SH, Dai AM, Wei HG, Yoon CH, Youn TJ, Chae IH, Kim CH
- KMID: 2522311
- Clin Hypertens.
- 2021;27(1):11.
- doi: 10.1186/s40885-021-00168-0
Background There have been concerns regarding the safety of renin-angiotensin-aldosterone-system (RAAS)-blocking agents including angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) during the coronavirus disease 2019 (COVID-19) pandemic. This study... -
- CITED
-
- Close
- SHARE
-
- Close
